Chronic administration of losartan plus hydrochlorothiazide improves vascular status in young cardiomyopathic hamsters

European Journal of Pharmacology

Volumn 420, Issue 2-3, 2001, Pages 133-141

  Crespo, María J ^a   De Mello, Walmor C ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Cardiomyopathic hamster; Heart failure; Hydrochlorothiazide; Losartan; Vascular function

Indexed keywords

ACETYLCHOLINE; DIPEPTIDYL CARBOXYPEPTIDASE; DIURETIC AGENT; ENDOTHELIN 1; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTERY TONE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; BODY MASS; CARDIOMYOPATHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME LOCALIZATION; HAMSTER; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; MALE; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; THICKNESS; VASCULAR RING;

ACETYLCHOLINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA, THORACIC; BODY WEIGHT; CARDIOMYOPATHIES; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; HYDROCHLOROTHIAZIDE; LOSARTAN; MALE; MESOCRICETUS; MYOCARDIUM; NITRIC OXIDE; ORGAN SIZE; PEPTIDYL-DIPEPTIDASE A; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS;

EID: 0035946971     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01006-8     Document Type: Article

References (41)

1. Telemetry for cardiovascular monitoring in a pharmacological study: New approaches to data analysis
2. Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model
3. Direct vascular actions of hydrochlorothiazide and indapamide in isolated small vessels
4. Nitric oxide: A physiological mediator of the type 2 (AT2) angiotensin receptor
5. Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function
6. Vascular alterations during the development and progression of experimental heart failure
7. Altered vascular function in early stages of heart failure
8. Concentrations of angiotensin converting enzyme activity in tissues of the rat
9. Correlation between changes in morphology, electrical properties, and angiotensin-converting enzyme activity in the failing heart
10. Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: Role of blood pressure and endothelial function
11. Ang II increases the release of endothelin-1 from human cultured endothelial cells but does not regulate its circulating levels
12. Effects of phosphoramidon, and BQ 788 on coronary and cardiac dysfunctions on the failing hamster heart
13. Myocardial contractility in relation to hypertrophy and failure in myopathic Syrian hamster
14. Cardiomyopathic Syrian hamster: A possible model of human disease
15. Effects of hydrochlorothiazide and captopril on the survival and heart weight of cardiomyopathic hamsters
16. Endothelin as a regulator of cardiovascular function in health and disease
17. Angiotensin AT(2) receptors mediate vasodepressor response to footshock in rats. Role of kinins, nitric oxide and prostaglandins
18. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system
19. Cardiomegaly and vasoactive hormones in rats with chronic myocardial infarction: Long-term effects of chlorothiazide
20. Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor
21. Angiotensin II stimulation in vitro induces hypertrophy of normal and postinfarcted ventricular myocytes
22. Losartan reduces constrictor responses to endothelin-1 and the thromboxane A2 analogue in aortic rings from spontaneously hypertensive rats: Role of nitric oxide
23. Role of macula densa in diuretics-induced renin release
24. Trends in hospitalization for health failure in Scotland 1980-1990
25. Activity of the L-arginine/nitric oxide pathway and endothelin-1 in experimental heart failure
26. Effects of thiazide diuretic on vascular eicosanoid system of spontaneously hypertensive rats
27. Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension
28. Effect of acute and chronic losartan therapy on active and inactive renin and active renin glycoforms
29. Angiotensin II-induced ET and PGI2 release in rat aortic endothelial cells is mediated by PKC
30. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomized trial - The Losartan Heart Failure Survival Study ELITE II
31. Involvement of nitric oxide, but not prostaglandins, in the vascular sympathoinhibitory effects of losartan in the pithed spontaneously hypertensive rat
32. Effects of losartan and enalapril on small artery structure in hypertensive rats
33. Endothelial dysfunction in spontaneously hypertensive rats: Consequences of chronic treatment with losartan or captopril
34. Molecular characterization of a dual endothelin-1/Ang II receptor
35. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat
36. Characterization and distribution of endothelin receptors in the pulmonary circulation: Investigation of isolated, perfused, and ventilated rabbit lungs
37. Hereditary and acquired cardiomyopathies in experimental animals; mechanical, biochemical and structural features
38. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: Pharmacological evaluation of nitric oxide synthase inhibitors
39. Stimulation of renin secretion by various methods: Optional results with hydrochlorothiazide
40. Antagonistic effects of losartan on thromboxane A2-receptors in human isolated gastroepiploic artery and saphenous vein
41. Quantitative and autoradiographic analyses of alpha-adrenergic and serotonergic receptors on aorta and coronary artery